The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population
Authors:
- 1 March 2015
- journal article
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 97 (2) , 137-139
Abstract
Introduction: The Nottingham Prognostic Index (NPI) is an established prognostication tool in the management of breast cancers (BCs). Latest ten-year survival data have demonstrated an improved outlook for each NPI category and the latest UK five- and ten-year survival from BC has been reported to be 85% and 77%, respectively. We compared survival of each NPI category for BCs diagnosed within the national breast screening service in Wales (Breast Test Wales (BTW)) to the latest data, and reviewed its validity in unselected cases within a screened population. Methods: All women screened between 1998 and 2001 within BTW were included. The NPI score for each cancer was calculated using the size, nodal status, and grade of the primary tumour. Survival data (all-cause) were calculated after ten years of follow-up. Results: In the three-year screening period, 199,082 women were screened. A total of 1,712 cancers were diagnosed, and 1,546 had data available for calculating the NPI. Overall five-year and ten-year survival was 94% and 82%, respectively. Conclusions: Overall five-year and ten-year survival (all-cause) has improved even when compared with UK data for BC-specific survival. We found that the NPI remains valid for BC treatment, and that our data provide a reference for updating the all-cause survival of women diagnosed with BCs within a screened population.Keywords
This publication has 13 references indexed in Scilit:
- Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 DecadesRadiology, 2011
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast CancerJournal of Clinical Oncology, 2005
- Incidence and prognosis in early onset breast cancerThe Breast, 2002
- Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institutionEuropean Journal of Cancer, 2001
- The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)Breast Cancer Research and Treatment, 1994
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Confirmation of a prognostic index in primary breast cancerBritish Journal of Cancer, 1987
- REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHYThe Lancet, 1985
- A prognostic index in primary breast cancerBritish Journal of Cancer, 1982